AVIS2SANTE
Software and AI products for public bodies, healthcare providers and enterprises, including conversational agents and telehealth
Highlights
- New on EvolcAdded 2026-11-03
About AVIS2SANTE
AVIS2SANTE develops and operates web and mobile software, AI agents, and the MonMedecin.org telehealth and appointment platform. GAIA Pilot automates calls, internal support, monitoring and reporting, and can integrate with customers’ information systems.
Its customers include public bodies, hospitals, healthcare organizations and large companies across sectors such as industry, finance and insurance. Products include incoming and outgoing call automation, teleconsultation, online scheduling and secure messaging.
The company was founded in 2016 and is headquartered in Six-Fours-les-Plages, France. Its products are used nationally, and it serves organizations including French ministries, university hospitals and healthcare groups.
Product: Develops and operates AI agents, web and mobile software, and the MonMedecin.org telehealth and appointment platform.
Jobs at AVIS2SANTE
More software & saas companies
avizi.fr
CRM and visitor-reception software for tourism offices and destination networks in FranceNew on EvolcAvm Integration
Urban, commercial and environmental strategy software for public-sector and business organizationsNew on EvolcAward Force
Awards management software for organisations running entry, judging and recognition programsNew on EvolcAxelor
Open-source ERP suite with no-code tools and AI agents for SMEs and large enterprises in manufacturing and servicesNew on EvolcAxeo System
Collaborative common data environment, document management and BIM platform for building projects run by owners, designers and contractorsNew on EvolcAxessim
Electromagnetic simulation software for aerospace, automotive, high-tech and defense engineering teamsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.